Investigational topical anticholinergics in clinical development for the treatment of hyperhidrosis

Stamatios Gregoriou,Anna Campanati,Dimitrios Rigopoulos,Anna Maria Offidani,Alexandros Stratigos,George Kontochristoulos
DOI: https://doi.org/10.1080/13543784.2021.1900114
2021-04-16
Expert Opinion on Investigational Drugs
Abstract:Focal hyperhidrosis has an incidence of up to 4.8%. % [<span class="ref-lnk lazy-ref"><a href="#">1</a></span>]. Abnormal sympathetic hyperactivity is the best documented component of its pathogenesis.
pharmacology & pharmacy
What problem does this paper attempt to address?